CASIN Real Estate Development Group (000838.SZ) signed the "Restructuring Investment Agreement" with pre-restructuring investors, and the stock has resumed trading.
*ST Development (000838.SZ) announced that on August 7, 2026, the company signed the Restructuring Investment Agreement of Financial Trust Real Estate Development Group Co., Ltd. with the leading investor Tianjin Jingxing New Energy Enterprise Management Consulting Co., Ltd. (abbreviated as "Tianjin Jingxing") and the Gongqingcheng Jingxing New Energy Industry Investment Partnership (Limited Partnership) (abbreviated as "Gongqingcheng Jingxing"). The company's stock will resume trading on August 10, 2026 (Monday) at the market opening.
CASIN Real Estate Development Group (000838.SZ) announced that on August 7, 2026, the company signed the "Restructuring Investment Agreement of Caixin Real Estate Development Group Co., Ltd." with Tianjin Jingxing New Energy Enterprise Management Consulting Co., Ltd. (referred to as "Tianjin Jingxing") and Gongqingcheng Jingxing New Energy Industry Investment Partnership (Limited Partnership) (referred to as "Gongqingcheng Jingxing"). The company's shares will resume trading on August 10, 2026 (Monday) at market open.
Although the "Restructuring Investment Agreement" has been signed, there may still be risks of the agreement being terminated, rescinded, declared invalid, or unable to be performed.
Related Articles
Verisilicon Microelectronics (Shanghai) Co., Ltd. (688521.SH) plans to introduce a restricted stock incentive plan in 2026.
Beijing InHand Networks Technology (688080.SH) plans to repurchase shares worth 20 million to 30 million yuan.
Sino Medical Sciences Technology Inc. (688108.SH) subsidiary's self-expanding intracranial drug-coated stent system has obtained EU MDR certification.
Verisilicon Microelectronics (Shanghai) Co., Ltd. (688521.SH) plans to introduce a restricted stock incentive plan in 2026.
Beijing InHand Networks Technology (688080.SH) plans to repurchase shares worth 20 million to 30 million yuan.
Sino Medical Sciences Technology Inc. (688108.SH) subsidiary's self-expanding intracranial drug-coated stent system has obtained EU MDR certification.
RECOMMEND
